Newsroom - Press Releases - Tetra Bio-Pharma

2020 2019 2018 2017 2016

12/06/2016

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma Via Private Placement to Fund Phyto Pain Pharma Clinical Trials

12/06/2016

Tetra Bio-Pharma Looks to Make Cannabis Affordable

11/23/2016

Tetra Bio-Pharma Provides USA Regulatory Update for its Cannabis Inhalation Product PPP001

11/21/2016

Tetra Bio-Pharma (GRPOF) Pioneers a New, Ancient Approach to Cannabinoid Delivery

11/16/2016

Tetra Bio-Pharma Achieves DTC Eligibility in the United States

11/14/2016

Tetra Bio-Pharma (GRPOF) Pioneers a New, Ancient Approach to Cannabinoid Delivery

11/04/2016

Tetra Bio-Pharma Inc. Announces the Closing of $914,456 Non-Brokered Private Placement

11/03/2016

Tetra Bio-Pharma Enters into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.

11/02/2016

Tetra Bio-Pharma Announces Outcome of its Meeting with its Scientific and Clinical Advisory Board

10/26/2016

Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through its Agro-Tek Subsidiary

10/20/2016

Tetra Bio-Pharma Inc. Announces a $750,000 Non-brokered Private Placement & Granting of Options

10/19/2016

Tetra BioPharma Announces Awarding of NSERC Engage Grant partnership to Grow Pros MMP and McGill University

10/07/2016

Tetra Bio-Pharma Secures $2M Equity Facility from New York Private Equity Firm

10/04/2016

Tetra Bio-Pharma Inc. annonce que sa demande de rencontre préalable (dite « pre-IND ») relative à son nouveau médicament de recherche a été acceptée

10/04/2016

Tetra Bio-Pharma Inc. Announces Its Pre-IND Meeting with FDA was Granted

09/29/2016

Tetra Bio-Pharma Inc. annonce que l’essai clinique de phase I sur la marijuana inhalée chez des volontaires en santé sera mené par Algorithme Pharma, une société membre d’Altasciences

09/29/2016

Tetra Bio-Pharma Inc. Announces That its Phase I Trial of Inhaled Marijuana in Healthy Volunteers Will Be Performed by Algorithme Pharma, an Altasciences Company

09/26/2016

PhytoPain Pharma Provides USA Regulatory Update for its Cannabis Inhalation Product PPP001

09/22/2016

PhytoPain Pharma annonce une entrevue avec Radio-Canada sur un médicament d’ordonnance à base de marijuana qu’elle met au point

09/22/2016

PhytoPain Pharma Announces Interview with Radio-Canada regarding its Development of a Prescription Marijuana Drug

09/06/2016

GCI Subsiduary PhytoPain Pharma Announces Submission of Orphan Drug Designation Application for Delta-9-tetrahydrocannibinol and Cannabidiol in the United States

08/26/2016

PhytoPain Pharma Announces Appointments to its Scientific and Clinical Advisory Board

08/25/2016

GROWPROS Announces Details of AGM